Thursday, August 27, 2015 12:09:47 AM
So long as YA continues its Q2 indication that it has ceased converting debentures, I agree there is potential.
However, IMO YA may view any extreme volume as an opportunity to restart the presses, at least temporarily. When the time comes, I might suggest you limit your 300M share acquisition to numerous moderate buys, otherwise it may not merely prohibit the pps from reaching .0002, it stands to lessen the overall potential for all common shareholders. (Not the most profound of statements, yet it needed to be said)
Simply stated, we need to avoid any additional dilution.
All of the above...JMO.
Best,
BC
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM